Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
+56,25% in 5 Tagen: Genialer Schachzug - diese Übernahme verändert alles
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
30 Leser
Artikel bewerten:
(0)

Intravascular Ultrasound (IVUS) - Global Trends, Estimates and Forecasts, 2012-2018

DUBLIN, Dec. 10, 2014 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/225lqn/intravascular) has announced the addition of the "Intravascular Ultrasound (IVUS) - Global Trends, Estimates and Forecasts, 2012-2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Global Intravascular Ultrasound (IVUS) sector is projected to reach US$618 million by 2016. The North America accounts for nearly 33% (2015) of the global share while Europe claims approximately 17% (2018). Asia-Pacific is the fastest growing region with a CAGR of 10.3% driving a market value of US$252 million by 2015. Among the product types, IVUS Catheters accounts nearly half of the market value while IVUS Consoles and IVUS Devices & Accessories add up to the remaining half.

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

Report Focus:

The report Intravascular Ultrasound (IVUS) - Global Trends, Estimates and Forecasts, 2012-2018' reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations.

Companies Mentioned:

  • 3M Healthcare
  • Abbott Vascular Devices
  • Abiomed, Inc.
  • Accellent, Inc.
  • Accutech, Llc
  • Advansource Biomaterials Corporation
  • Aerotel Medical Systems, Ltd.
  • Alere, Inc.
  • All Pro Corporation
  • Ambu A/S
  • Angiodynamics, Inc.
  • Aortech International, Plc.
  • Apc Cardiovascular, Ltd.
  • Aptus Endosystems, Inc.
  • Arterial Remodeling Technologiesuscome Limited
  • Asahi Intecc Co., Ltd.
  • Asahi Kasei Corporation
  • Ash Access Technology, Inc.
  • Asian Heart Institute
  • Atcor Medical Holdings Limited
  • Atricure, Inc.
  • Atrium Medical Corporation
  • Baxter International Inc.
  • Becton, Dickinson & Co.
  • Beijing Anzhen Hospital
  • Berlin Heart Gmbh
  • Bioclinica
  • Bioheart, Inc.
  • Biophan Technologies, Inc.
  • Biosense Webster, Inc.
  • Biosensors International Group, Ltd.
  • Biotelemetry, Inc.
  • Bioteque Corporation
  • Biotronik Gmbh & Co. Kg.
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cambridge Heart, Inc.
  • Cardiac Science Corporation
  • Cardiacassist, Inc.
  • Cardica, Inc.
  • Cardiocomm Solutions, Inc.
  • Cardiorobotics, Inc.
  • Cardiovascularsystems, Inc.
  • Cardium Therapeutics, Inc.
  • Cardiva Medical, Inc.
  • Cathrx Ltd
  • Circulite, Inc.
  • Compumed, Inc.
  • Conmed Corporation
  • Cook Group Incorporated
  • Cordis Corporation
  • Covidien Plc
  • Cryolife Inc.
  • Deltex Medical Group Plc
  • Digirad Corporation
  • Dräger Medical Ag & Co. Kg
  • Edwards Lifesciences, Llc.
  • Endologix Incorporated
  • Esaote S.P.A
  • Fleming Medical Limited
  • Fluxion
  • Fudan University Zhongshan Hospital
  • Fukuda Denshi Co., Ltd.
  • Gamida Cell Ltd.
  • Ge Healthcare
  • Goodman Co., Ltd.
  • Greatbatch, Inc.
  • Heartware Ltd.
  • Hospira, Inc.
  • Indraprastha Apollo Hospital
  • Inspiremd Ltd.
  • Interface Biologics, Inc.
  • Issys Sensing Systems, Inc
  • Itgi Medical Ltd.
  • Johnson & Johnson
  • Key Company
  • Koninklijkedsm N.V.
  • Lepu Medical
  • Levitronix, Llc
  • Lidco Group Plc
  • Lombard Medical Technologies Plc
  • Maquet Gmbh & Co. Kg
  • Medinol, Ltd.
  • Medrad, Inc.
  • Medtronic, Inc.
  • Meridian Health System, Inc
  • Merit Medical Systems, Inc.
  • Microports Medical
  • Millar Instruments, Inc
  • Molecular Devices, Llc
  • Monebo Technologies, Inc.
  • Mortara Instrument, Inc.
  • Narayana Hrudayalaya
  • Nihon Kohden Corporation
  • Novadaq Technologies Inc.
  • Opto Circuits India Limited
  • Philips Medical Systems
  • Pulsion Medical Systems Se
  • Sahajanand Medical Technologies Pvt.,Ltd.
  • Scottcare Cardiovascular Solutions
  • Sichuan Jinjiang Electronic Science And Technology Co., Ltd
  • Siemens Medical Solutions Usa, Inc.
  • Smith & Nephew Plc
  • Sonosite, Inc.
  • Sophion Bioscience A/S
  • Sorin Group Usa, Inc.
  • Spectranetics International B.V
  • St. Jude Medical
  • Stereotaxis, Inc.
  • Sunshine Heart, Inc.
  • Surgical Specialisties Corporation
  • Syncardia Systems, Inc.
  • Teleflex, Inc.
  • Terumo Cardiovascular Systems Corporation
  • Terumo Heart, Inc.
  • Thermedics, Inc.
  • Thoratec Corporation
  • Ttk Healthcare
  • Varian Medical Systems, Inc.
  • Vascular Concepts
  • Vicor Technologies, Inc.
  • Volcano Corporation

For more information visit http://www.researchandmarkets.com/research/225lqn/intravascular

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.